Enter Symbol click to research


Company

Research Notes

Community


Analysis

Blog Articles
 

Charts

Technical Charts

Analyst

Analyst Ratings
Analyst Estimates
 
Sales Estimates
 

Ratios

Technicals
 

INTEGR BIO(OTC:INBP)
Integrated BioPharma, Inc. is a well-established biopharma company serving the varied needs of the nutraceutical, biotech and pharmaceutical industries. Through a number of wholly owned subsidiaries INB develops, manufactures and distributes, worldwide over 130 products.
# Employees: 115
Address: 201 ROUTE 22,HILLSIDE,NJ,USA
Phone: 973-926-0816
Fax: 973-926-1735
Website: http://www.integratedbiopharma.com
Email:
Sector: Medical
Industry: MED-DRUGS
Executive Officers
E. Gerald Kay (Chief Executive Officer)
Dina L. Masi (Chief Financial Officer)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 6/30/2013
Next Earnings Date(Expected): 11/18/2013
Mean EPS (Next Qtr): ($0.01)
Mean EPS (Year): ($0.01)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 0
Shares Performance
Period INBP Compare to S&P
YTD -5.00 % -23.48 %
4 Weeks -24.00 % -26.89 %
12 Weeks 1.33 % -5.24 %
Shares Information
Analyst Coverage: N
Avg Volume: 6955
Shares Outstanding: 21M
Market Cap: $0.00B
52 Week High: $0.23
52 Week Low: $0.12
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 1/1/1990 INBP split by factor of 0.250
Earnings Performance
EPS Growth in Last Quarter: 200.00 %
EPS Growth in Last Year: 142.86 %
Sales Growth in Last Quarter: 17.71 %
Sales Growth in Last Quarter: 25.85 %
Financials
Qtr Book Value: ($0.01)
Cash Flow/Share: $2.37
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.